Multiple Endocrine Neoplasia
A group of autosomal dominant diseases characterized by the combined occurrence of tumors involving two or more ENDOCRINE GLANDS that secrete PEPTIDE HORMONES or AMINES. These neoplasias are often benign but can be malignant. They are classified by the endocrine glands involved and the degree of aggressiveness. The two major forms are MEN1 and MEN2 with gene mutations on CHROMOSOME 11 and CHROMOSOME 10, respectively.
Subtype terms (3)
More specific conditions that are subtypes of Multiple Endocrine Neoplasia in the MeSH hierarchy.
- Multiple Endocrine Neoplasia Type 1
10 drugs (9 approved, 1 experimental)
- Multiple Endocrine Neoplasia Type 2a
5 drugs (4 approved, 1 experimental)
- Multiple Endocrine Neoplasia Type 2b
5 drugs (4 approved, 1 experimental)
Drugs by status
Phase 4 trials (1)
Phase 2 trials (5)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 2 Indications (9)
Organization Involved with Phase 1 Indications (2)